Wednesday 6 July 2016

Pernix Therapeutics (PTX) stock: three simple reasons why I like it

I like Pernix Therapeutics (PTX) stock for three simple reasons:

1) Billionaire Steve Cohen has a stake in this stock and has increased his stake in it (related report here)

2) Many institutional shareholders of this stock and the products of PTX have potential to continue to do well (related report here)

3) CEO of Pernix, John Sedor seems to have a track record of leading companies to acquisition (related report here). John Sedor is also the Chairman and CEO of Sedor Pharmaceuticals and acquisition records of the companies he has been involved could be found in this link.

If you like my post, please Like K8Investing Facebook or K8Investing Twitter page to get instant updates about the search for the next US multi-bagger stocks! If you wish to receive FREE Regular Newsletters about K8 Investing's views on US stocks and investments, please click this link here.